Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators.
Halpin, David M
Kaplan, A G
Russell, R K
RightsArchived with thanks to Respiratory medicine
MetadataShow full item record
Chronic obstructive pulmonary disease (COPD) and asthma are leading causes of morbidity and mortality. This narrative review provides an appraisal of the pharmacological and clinical characteristics of tiotropium in COPD and asthma, and examines how these compare with other long-acting bronchodilators. The evidence base is placed into context by relating it to factors affecting clinicians' choice of therapy.